SCHEMBL8041985

SCHEMBL8041985

Cc1ccc2oc(C=O)cc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.46
KDM4E B2RXH2 8/20 0.38
NPC1 O15118 6/20 0.38
RAB9A P51151 6/20 0.38
ALDH1A1 P00352 6/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 4/20 0.38
TP53 P04637 3/20 0.38
CYP1A2 P05177 3/20 0.37
GAA P10253 4/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
MAPT P10636 5/20 0.36
POLB P06746 2/20 0.36
CASP3 P42574 2/20 0.36
SENP7 Q9BQF6 2/20 0.36
SENP6 Q9GZR1 2/20 0.36
SENP8 Q96LD8 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7916567 0.75 CYP1A2 (0.48) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL1165531 0.72 CYP1A2 (0.41) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL30528375 0.72 CYP1A2 (0.41) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL1397762 0.70 CYP2A6 (0.62) CYP2A6ALDH1A1ADORA3
SCHEMBL12317671 0.70 KDM4E (0.41) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4820686 0.69 CYP2A6 (0.52) CYP2A6KDM4ENPC1RAB9AALDH1A1
SCHEMBL29935718 0.69 CYP2A6 (0.52) CYP2A6KDM4ENPC1RAB9AALDH1A1
SCHEMBL23293854 0.68 CYP2A6 (0.42) CYP2A6ADORA3
SCHEMBL2818516 0.68 GAA (0.51) CYP2A6KDM4ENPC1RAB9AALDH1A1
SCHEMBL30947758 0.68 CYP2A6 (0.42) CYP2A6ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256299-A1 7-MORPHOLINO-5-(3-PHENYL-1 H-PYRAZOL-1 -YL)-FURO[3,2-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PIKFYVE KINASE INHIBITORS FOR THE TREATMENT OF E.G. AMYOTROPHIC LATERAL SCLEROSIS (ALS) Verge Analytics, Inc. (US) 2022-12-08 WO disclosed
WO-2000076990-A1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2000-12-21 WO disclosed